-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Reiterates Buy on Ionis Pharmaceuticals, Maintains $86 Price Target

Benzinga·09/04/2026 15:59:19
语音播报
Needham analyst Joseph Stringer reiterates Ionis Pharmaceuticals (NASDAQ:IONS) with a Buy and maintains $86 price target.